<?xml version="1.0"?>
<Articles JournalTitle="Acta Biochimica Iranica">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Biochimica Iranica</JournalTitle>
      <Issn>0001-5261</Issn>
      <Volume>1</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2023</Year>
        <Month>08</Month>
        <Day>23</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Association between Steroid Hormones and Insulin Resistance in Patients with Polycystic Ovary Syndrome</title>
    <FirstPage>26</FirstPage>
    <LastPage>31</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Nima</FirstName>
        <LastName>Taghizadeh</LastName>
        <affiliation locale="en_US">Hazrat Aliasghar Children&#x2019;s Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Soha</FirstName>
        <LastName>Mohammadi</LastName>
        <affiliation locale="en_US">Hazrat Aliasghar Children&#x2019;s Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Vahid</FirstName>
        <LastName>Saeedi</LastName>
        <affiliation locale="en_US">Pediatric Endocrinology and Metabolism Department, School of Medicine, Iran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Ladan</FirstName>
        <LastName>Haghighi</LastName>
        <affiliation locale="en_US">Department of Obstetrics and Gynecology, Akbar-Abadi Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mona</FirstName>
        <LastName>Nourbakhsh</LastName>
        <affiliation locale="en_US">Hazrat Aliasghar Children&#x2019;s Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mitra</FirstName>
        <LastName>Nourbakhsh</LastName>
        <affiliation locale="en_US">Department of Biochemistry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Razzaghy Azar</LastName>
        <affiliation locale="en_US">Hazrat Aliasghar Children&#x2019;s Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2023</Year>
        <Month>08</Month>
        <Day>23</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Objectives: Women with Polycystic Ovary Syndrome (PCOS) are more prone to adverse outcomes, including hypertension, obesity, hyperlipidemia, insulin resistance, type 2 diabetes mellitus, metabolic syndrome, and cardiovascular disease. This study examined the potential link between abnormal steroid hormone levels and insulin resistance (IR) in reproductive-aged women with PCOS.
Methods: This study involved 61 participants: a case group of 33 patients with confirmed PCOS based on Rotterdam criteria and a control group of 28 healthy individuals without PCOS. Steroid hormone levels, IR indices, metabolic markers, and demographic characteristics of participants were measured.
Results: The results showed significant differences in testosterone (P=0.018), dihydrotestosterone (DHT) (P=0.009), and androstenedione (P=0.002) levels between the two groups. Insulin levels and HOMA-IR were significantly higher in the patients (P=0.034 and 0.025, respectively). Significant correlations were found between androstenedione and insulin (P=0.021), fasting blood sugar, and homeostatic model assessment of insulin resistance (HOMA-IR) levels (P=0.001), as well as between DHT level and IR indices (P=0.03). Additionally, patients with PCOS had higher diastolic blood pressure and lower levels of T4.
Conclusion: The findings of this study showed higher androgen levels in PCOS patients and a significant correlation between DHT and androstenedione levels with IR indices in PCOS patients, which establishes a remarkable connection between hyperandrogenism and insulin resistance in PCOS.</abstract>
    <web_url>https://abi.tums.ac.ir/index.php/abi/article/view/18</web_url>
    <pdf_url>https://abi.tums.ac.ir/index.php/abi/article/download/18/11</pdf_url>
  </Article>
</Articles>
